Strategies to tackle RAS-mutated metastatic colorectal cancer

The RAS oncogene is among the most commonly mutated in cancer. RAS mutations are identified in about half of patients diagnosed with metastatic colorectal cancer (mCRC), conferring poor prognosis and lack of response to anti-epidermal growth factor receptor (EGFR) antibodies. In the last decades, se...

詳細記述

保存先:
書誌詳細
出版年:ESMO Open
主要な著者: Patelli, G., Tosi, F., Amatu, A., Mauri, G., Curaba, A., Patanè, D.A., Pani, A., Scaglione, F., Siena, S., Sartore-Bianchi, A.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2021
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167159/
https://ncbi.nlm.nih.gov/pubmed/34044286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100156
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料